Trial Profile
Pilot study on glycaemic variability in type 2 diabetes mellitus patients with basal insulin and fixed combo oral antidiabetic treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Antihyperglycaemics; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 05 Aug 2008 Primary endpoint identified as self monitoring blood glucose values as reported by ClinicalTrials.gov.
- 05 Aug 2008 The expected completion date for this trial is now 1 May 2006 as reported by Clinicaltrials.gov.
- 24 Nov 2006 Status change